HOME >> MEDICINE >> NEWS
AAPS workshop to explore pharmaceutical reference standards

The American Association of Pharmaceutical Scientists (AAPS) will present the AAPS Workshop on Reference Standards: Science, Methodologies and Compliance of Current and Emerging Pharmaceutical Products, May 15-16, 2000 at the Crystal Gateway Marriott in Arlington, Va.

"This is the first workshop in several years dedicated exclusively to pharmaceutical reference standards," said Moheb M. Nasr, Ph.D., Food and Drug Administration. "This workshop will not only educate new scientists but will also provide more experienced scientists and managers a forum for discussion."

The objective of the workshop is to provide an update on current and emerging issues in the development, characterization and use of reference standards. The workshop will be of particular interest to pharmaceutical scientists working in analytical research and development, quality assurance and control, regulatory affairs and compliance and related disciplines.

Workshop topics include:

  • Evolution of reference standards throughout drug discovery, development and post-marketing
  • Characterization of Reference Standard Materials using a variety of analytical techniques
  • Compendial review of and approval process (U.S. Pharmacopeia and International Pharmacopeias)
  • Practical considerations for a successful reference standard program: maintenance, storage, use and requalification
  • Reference standards used in the analysis of biotechnological and botanical drug products.
  • Use of reference standards in comparitor studies for New Chemical Entities Reference standards used in the calibration and qualification of laboratory instruments
  • Analytical approaches when reference standards are not available


'"/>

Contact: Debbie Mierke
mierke@aaps.org
703-248-4743
American Association of Pharmaceutical Scientists
30-Apr-2000


Page: 1

Related medicine news :

1. NIH convenes workshop on menopausal hormone therapy
2. Hands-on cancer biology workshop for journalists
3. AAPS kicks off new century with workshop on bioanalytical methods validation
4. PQRI workshop to address blend uniformity
5. AAPS workshop to explore regulatory approaches to bioavailability, bioequivalence
6. AAPS workshop to examine changes in analytical methods and packaging
7. AAPS presents workshop on macromolecules
8. NPSF workshop builds community to improve pharmaceutical safety
9. Researcher explores ways to make hypnosis a more effective therapeutic technique
10. Impact of scientific advances on drug studies and membrane research to be explored
11. Study explores risks of obesity in children with kidney transplants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Dr. Andrew Lian-Jie ... fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research training at the ... internship in internal medicine at the Emory University and dermatology training at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... treatments for patients with sleep apnea and TMJ disorders. These conditions are quite ... health. Dr. Rassouli provides personalized care to reduce the risk of these consequences ...
(Date:1/19/2017)... ... 19, 2017 , ... Rountree Brady Insurance Agency, a Savannah ... eastern Georgia, is embarking on a charity effort to raise awareness and gather ... every year than anything else, yet risk factors associated with heart disease are ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages to prevent distracted ... from Impact Teen Drivers and California Casualty. Entries from students aged 14-22 can ... totaling $15,000 will be awarded for the best peer-to-peer messages sharing solutions to ...
(Date:1/19/2017)... ... ... The 21st Century Cures Act’s Impact on Medical Devices:, What You Need ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do manufacturers ... year? , The passage of the act means devicemakers will be scrambling to meet ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Shire plc (LSE: SHP, NASDAQ: ... Drug Administration (FDA) has acknowledged receipt of the Class ... SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 ... Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide ... designated Prescription Drug User Fee Act (PDUFA) action date. ...
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... The Global Therapy Partnering Terms and Agreements since 2010 ... agreements entered into by the world,s leading healthcare companies. ... by value - Deals listed by company A-Z, industry ... provides understanding and access to the partnering deals and ... The report provides an analysis of partnering deals. ...
Breaking Medicine Technology:
Cached News: